Chapter 17-103 - PRESCRIPTION DRUG MONITORING PROGRAM
- Rule 17-10300 - GENERAL PROVISIONS
- Rule 17-10301 - PRESCRIPTION MONITORING DATA REPORTING REQUIREMENTS
- Rule 17-10302 - COVERED SUBSTANCES
- Rule 17-10303 - STANDARDS AND FORMAT FOR REPORTING
- Rule 17-10304 - ZERO REPORTING
- Rule 17-10305 - CRITERIA FOR GRANTING WAIVERS OF THE REPORTING REQUIREMENTS
- Rule 17-10306 - PRESCRIBER AND DISPENSER ACCESS TO PRESCRIPTION MONITORING DATA
- Rule 17-10307 - MANDATORY DISCLOSURE OF PRESCRIPTION MONITORING INFORMATION FOR LAW ENFORCEMENT AND REGULATORY PURPOSES
- Rule 17-10308 - DISCRETIONARY DISCLOSURE OF INFORMATION
- Rule 17-10309 - INTEROPERABILITY WITH OTHER STATE PRESCRIPTION DRUG MONITORING PROGRAMS
- Rule 17-10310 - NOTICE OF REQUESTS FOR INFORMATION
- Rule 17-10311 - CONFIDENTIALITY
- Rule 17-10312 - REQUESTS TO PROGRAM TO CORRECT PRESCRIPTION MONITORING DATA
- Rule 17-10313-10315 - RESERVED
- Rule 17-10316 - THE PDMP ADVISORY COMMITTEE
- Rule 17-10399 - DEFINITIONS